Dr. Jonathan C Roberts, MD
Claim this profileBleeding and Clotting Disorders Institute
Studies Von Willebrand Disease
Studies Hemophilia A
8 reported clinical trials
7 drugs studied
Area of expertise
1Von Willebrand Disease
VWF collagen binding positive
VWF activity positive
VWF antigen positive
2Hemophilia A
VWF collagen binding positive
VWF activity positive
VWF antigen positive
Affiliated Hospitals
Clinical Trials Jonathan C Roberts, MD is currently running
Emicizumab
for Hemophilia A
This is a phase II multicenter open-label, single-arm prospective study to evaluate the efficacy of prophylactic emicizumab administered on a scheduled basis to prevent bleeds in patients with acquired hemophilia A (AHA).
Recruiting1 award Phase 2
Shockwave Therapy
for Coronary Artery Disease
This investigational device exemption (IDE) study is to assess the safety and effectiveness of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2+ 2Hz Coronary IVL Catheter to treat de novo, calcified, stenotic, coronary lesions prior to stenting.
Recruiting1 award N/A10 criteria
More about Jonathan C Roberts, MD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Jonathan C Roberts, MD has experience with
- Emicizumab
- Wilate
- CLBS16
- Placebo
- Antihemophilic Factor (Recombinant)
- Von Willebrand Factor (Recombinant)
Breakdown of trials Jonathan C Roberts, MD has run
Von Willebrand Disease
Hemophilia A
Coronary Artery Disease
Microvascular Angina
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan C Roberts, MD specialize in?
Jonathan C Roberts, MD focuses on Von Willebrand Disease and Hemophilia A. In particular, much of their work with Von Willebrand Disease has involved VWF collagen binding positive patients, or patients who are VWF activity positive.
Is Jonathan C Roberts, MD currently recruiting for clinical trials?
Yes, Jonathan C Roberts, MD is currently recruiting for 4 clinical trials in Peoria Illinois. If you're interested in participating, you should apply.
Are there any treatments that Jonathan C Roberts, MD has studied deeply?
Yes, Jonathan C Roberts, MD has studied treatments such as Emicizumab, Wilate, CLBS16.
What is the best way to schedule an appointment with Jonathan C Roberts, MD?
Apply for one of the trials that Jonathan C Roberts, MD is conducting.
What is the office address of Jonathan C Roberts, MD?
The office of Jonathan C Roberts, MD is located at: Bleeding and Clotting Disorders Institute, Peoria, Illinois 61614 United States. This is the address for their practice at the Bleeding and Clotting Disorders Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.